Synopsis:
Abnormal activation of NF-κB signalling pathway plays a crucial role in cancer inflammation. In Cancer Cell, Liu et al, identify a novel lncRNA, NKILA, that is a negative feedback regulator of NF-κB, thus represses NF-κB signalling and cancer-associated inflammation.